Profiel
Lee Swem formerly worked at Achaogen, Inc., as Chief Scientific Officer from 2017 to 2018.
Dr. Swem received his doctorate degree from Indiana University.
Eerdere bekende functies van Lee Swem
| Bedrijven | Functie | Einde |
|---|---|---|
| ACHAOGEN | Hoofd Techniek/Wetenschap/O&O | 24-09-2018 |
Opleiding van Lee Swem
| Indiana University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
